Biomerica, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMRA research report →
About the company
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications.
- CEO
- Zackary S. Irani
- IPO
- 1984
- Employees
- 64
- HQ
- Irvine, CA, US
Price Chart
- Market Cap
- $5.41M
- P/E
- -1.26
- P/S
- 1.25
- P/B
- 1.59
- EV/EBITDA
- -1.14
- Div Yield
- 0.00%
- Gross Margin
- 4.32%
- Op Margin
- -123.74%
- Net Margin
- -96.49%
- ROE
- -98.14%
- ROIC
- -152.51%
- Revenue
- $5.31M · -1.92%
- Net Income
- $-4,973,000 · 16.81%
- EPS
- $-2.16 · -500.00%
- Op Income
- $-5,137,000
- FCF YoY
- 29.18%
- 52W High
- $4.60
- 52W Low
- $1.73
- 50D MA
- $2.13
- 200D MA
- $2.37
- Beta
- 0.33
- Avg Volume
- 18.33K
Get TickerSpark's AI analysis on BMRA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 12, 25 | Chin Eric | other | 22,500 |
| Dec 12, 25 | Lu Gary | other | 40,000 |
| Dec 12, 25 | Irani Zackary S. | other | 52,500 |
| Dec 12, 25 | BARBIERI ALLEN | other | 30,000 |
| Dec 12, 25 | MOATAZEDI DAVID | other | 20,000 |
| Dec 12, 25 | Gary M. Huff | other | 20,000 |
| Jun 4, 25 | Chin Eric | other | 0 |
| Dec 13, 24 | Emerson Jane | other | 85,000 |
| Dec 13, 24 | Irani Zackary S. | other | 250,000 |
| Dec 13, 24 | BARBIERI ALLEN | other | 110,000 |
Our BMRA coverage
Recent articles, reports, and earnings notes.
No research on BMRA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMRA report →Similar companies
Peers in the same neighborhood.